RHDV2 is an extremely lethal virus that spreads easily among rabbits. Veterinarians can now protect rabbits with a highly effective vaccine from Medgene Labs.
Category: Press Release
Medgene’s Innovative Vaccine Initiative for RHDV2
Medgene Labs has been working on a solution to RHDV2 since the 2020 outbreak. Recently granted emergency-use authorization by the USDA, the vaccine uses genetically modified cells that are injected so that the body creates the proteins.
Minnesota Zoo Conducting EHD Vaccine Study with Medgene
Medgene EHD Vaccine Tested at Minnesota Zoo
Minnesota Zoo Tests Vaccine Against Spread of Emerging Deer VirusThis article was published in the Star Tribune on October 26, 2021 by Greg Stanley. Vaccine being tested against killer disease carried by biting gnat. The reindeer at the Minnesota Zoo are all still alive and healthy this fall, showing early promise that the zoo may be able… Continue reading Medgene EHD Vaccine Tested at Minnesota Zoo
Medgene Receives Emergency Use Authorization for RHDV2 Vaccine
Rabbit Hemorrhagic Disease has quickly spread across the United States. Working with the USDA, Medgene Labs responds with a vaccine developed on its prescription platform technology. Medgene Labs, a vaccine and immunological services provider based in Brookings, SD, has received emergency use authorization for their experimental Rabbit Hemorrhagic Disease Virus 2 (RHDV2) vaccine from the… Continue reading Medgene Receives Emergency Use Authorization for RHDV2 Vaccine
Next Evolution of Vaccine Technology
USDA-approved prescription platform creates new opportunity for producers and veterinarians to proactively address emerging and constantly-changing viruses affecting animal health. Medgene Labs, a vaccine and immunological services provider based in Brookings, SD, has received regulatory approval for their prescription platform swine vaccines from the USDA Center for Veterinary Biologics (CVB). As one of the first companies… Continue reading Next Evolution of Vaccine Technology
